RecruitingPhase 2Phase 3NCT06196515

Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication

Evaluation of the Antibacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication: A Randomized Clinical Trial


Sponsor

British University In Egypt

Enrollment

54 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.


Eligibility

Min Age: 21 YearsMax Age: 49 Years

Inclusion Criteria4

  • healthy males and females.
  • age range between 21-49.
  • patients with no physical disability or psychological problems.
  • patients presenting with single permanent molar with signs and/or symptoms of apical periodontitis, and having Periapican index ≥ 2.

Exclusion Criteria6

  • pregnant women.
  • patients with immune-compromised disease.
  • patients with complicated systemic diseases.
  • patients who took antibiotics within a period of 1 month.
  • patients with known sensitivity to the medicaments or pharmaceuticals used in this study.
  • Non-restorable teeth including root fractures, and/or advanced periodontal involvement.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCalcium hydroxide

placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.

DRUGnano calcium hydroxide

placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.


Locations(1)

british university in Egypt - dentistry collage

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06196515


Related Trials